MedTrace Logo

Lactoferrin for Treatment of Iron Deficiency Anemia.

NCT04435574 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-06-17

No results posted yet for this study

Summary

Anemia is a great public health problem affecting both developing and developed countries. Iron deficiency anemia represents about 50% of causes of anemia worldwide.

Lactoferrin fortified milk has a positive effect on Hb and iron status of infants.

the hypothesis of this study is "lactoferrin may have comparable efficacy to ferrous sulfate therapy with more tolerability and fewer side effects".

the research question of this study is whether oral lactoferrin is effective for treatment of iron deficiency anemia, compared to traditional ferrous sulfate therapy regarding hemoglobin rise and side effects and tolerability.

Conditions

  • Anemia, Iron Deficiency

Interventions

DRUG

Lactoferrin

Bovine Lactoferrin 100mg sachets.

DRUG

Ferrous Sulfate

6mg/kg of ferrous sulfate.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ghada Khfaji, Associate professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-05
Primary Completion
2019-04-01
Completion
2019-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04435574 on ClinicalTrials.gov